The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MPN Workshop of the Carolinas 2024 | Changing attitudes to using interferon in pediatric patients with MPNs
Nicole Kucine, MD, MS, Weill Cornell Medicine, New York, NY, discusses the use of interferon in pediatric patients with myeloproliferative neoplasms (MPNs), commenting on whether clinicians have become more comfortable with prescribing this therapeutic option in the pediatric patient population. Dr Kucine expresses hope that prospective clinical trials will be initiated to investigate the use of ropeginterferon in young patients. This interview took place at the 1st Annual MPN Workshop of the Carolinas in Asheville, NC.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Consultancy: PharmaEssentia, Protagonist Therapeutics; Conference speaker: AOP Health.
